According to the recent research report titled ‘Artificial Organs Market Size By Organ Type (Artificial Kidney, Artificial Liver, Artificial Lungs, Artificial Pancreas, Artificial Heart), By Material Type (Silicon, Plastic, Steel), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026’, available with Market Study Report, global artificial organs market size is expected to grow manifold over 2020-2026.
 

Rising technological advancements, increasing cases of organ failure, and lack of organ donors are favoring global artificial organs market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2361898/
 

For the unversed, artificial organs are human-made tissues or organs that are implanted or integrated into the human body and interfaced with living tissues to replace or improve the function of a natural organ. Research & development in the field is projected to pick pace, with biotechnology companies at the forefront.
 

Considering challenges, growing pervasiveness of infections due to material used for artificial organ development, high cost, and chances of failure after transplantation are negatively impacting the business scenario.
 

As per organ type, artificial pancreas segment is expected to record a CAGR of 9.5% over 2020-2026, attributable to increasing cases of diabetes and ongoing efforts in new product development. Artificial pancreas can help people with diabetes or other gastrointestinal problems to transfer insulin across membranes in response to glucose and fatty acids. It is utilized to mimic the endocrine activity of a healthy pancreas in patients who require it.
 

Elaborating on material type, silicon segment is anticipated to seize 35% of global artificial organs industry share by the year 2026. Silicon nano porous membranes, produced on a silicon support structure, and coated with polyethylene glycol (PEG) can be used to mimic most of the features and functions of healthy natural organs. Several research groups are investigating how silicon nano-porous membranes can be used to develop artificial kidneys and protect transplanted pancreas tissues from immune destruction.
 

Geographically, Asia Pacific industry share is projected to register 9.5% CAGR through 2026, creditable to rising incidences of organ failures and scarcity of organ donors. The region has seen a significant increase in the occurrence of orthopedic ailments, especially among the elderly population, as older individuals are more prone to various health issues. Such trends are boosting the adoption of modern healthcare products and equipment.
 

Key players influencing worldwide artificial organs market dynamics are SynCardia Systems LLC, Ottobock, Nipro Corporation, Cochlear Ltd., Baxter International Inc., Zimmer Biomet, Ekso Bionics Holdings Inc., Boston Scientific Corporation, Berlin Heart GmbH (Syscore GmbH), and Medtronic plc.